Ferrous Sulfate Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Ferrous sulfate is an iron-based chemical compound produced mainly as ferrous sulfate heptahydrate (FeSO₄·7H₂O) and monohydrate (FeSO₄·H₂O), used extensively as a coagulant in water and wastewater treatment, an iron supplement in pharmaceuticals, a soil micronutrient in agriculture, and an additive in cement and industrial processes. The market was valued at approximately USD 2.65 billion in 2024, with projections indicating steady growth toward roughly USD 3.4-4.2 billion by 2030 depending on scenario assumptions. Production is concentrated among chemical manufacturers leveraging both mined byproduct sources and synthetic production routes, with supply chains spanning North America, Europe, and Asia-Pacific.

• •Market valued at ~USD 2.65 billion in 2024, growing at ~5.0% CAGR through 2030-2032
• •Primary product forms: Ferrous Sulfate Heptahydrate (dominant) and Monohydrate
• •Key applications: water treatment coagulant, pharmaceutical iron supplement, agricultural micronutrient, and industrial chemical

The water treatment sector remains the largest end-use driver, as ferrous sulfate serves as a cost-effective coagulant for removing phosphates, heavy metals, and sulfide odors from municipal and industrial wastewater, supported by tightening global discharge regulations. In agriculture, rising soil micronutrient deficiency awareness and demand for iron-enriched fertilizers, particularly in regions with calcareous or alkaline soils, are expanding consumption. The pharmaceutical segment is sustained by a growing global burden of iron-deficiency anemia, particularly among women and children in developing economies, alongside aging populations in developed markets requiring iron supplementation.

• •Stringent wastewater treatment regulations worldwide driving coagulant demand across municipal and industrial sectors
• •Rising prevalence of iron-deficiency anemia and expanding pharmaceutical formulations using ferrous sulfate as a primary active ingredient
• •Agricultural soil amendment demand growing due to micronutrient-deficient soils and increasing precision farming practices

By product type, ferrous sulfate heptahydrate commands the majority share due to its stability and solubility profile suited for most applications, while monohydrate serves niche pharmaceutical and specialty industrial uses. By application, water treatment, agriculture, pharmaceuticals, and cement additives represent the core segments, with distribution varying significantly by region. Asia-Pacific dominates the market, led by China and India's large-scale water treatment infrastructure and agricultural sectors, while Europe and North America follow with stable demand driven by mature pharmaceutical markets and regulated environmental standards.

• •Asia-Pacific is the leading regional market, anchored by China's vast industrial and agricultural demand
• •Heptahydrate form accounts for the largest product-segment share across most applications
• •Water treatment and agriculture together represent the two largest application segments globally

What are the recent trends and outlook?

Sustainability and circular economy principles are influencing the market, with increasing emphasis on recovering ferrous sulfate as a value-added byproduct from steel mill pickling liquor and titanium dioxide manufacturing, reducing reliance on dedicated synthesis and lowering environmental footprint. Pharmaceutical-grade ferrous sulfate production is seeing incremental upgrades to meet tightening Good Manufacturing Practice (GMP) standards, particularly for pediatric and prenatal formulations. Looking ahead, the market is expected to maintain its ~5.0% growth trajectory through 2032, with emerging market infrastructure development, expanding wastewater treatment coverage, and rising nutritional supplement demand serving as primary tailwinds.

• •Byproduct recovery from steel and TiO₂ industries gaining prominence as a sustainable production model
• •Pharmaceutical-grade segment tightening quality standards to meet global GMP and regulatory requirements
• •Market projected to reach between USD 3.4 billion and USD 4.2 billion by 2030 depending on source assumptions